A carregar...
Time to re-evaluate effects of renin-angiotensin system inhibitors on renal and cardiovascular outcomes in diabetic nephropathy
The use of renin-angiotensin system (RAS) inhibitors, such angiotensin converting enzyme inhibitors/angiotensin-II receptor blockers, to slow progression of chronic kidney disease (CKD) in a large group dominated by elderly people in the real world is not supported by available evidence. Large-scale...
Na minha lista:
| Publicado no: | World J Nephrol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4317622/ https://ncbi.nlm.nih.gov/pubmed/25664254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5527/wjn.v4.i1.118 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|